Benjamin Batalha, aged 35, died in custody at Arthur Gorrie Correctional Centre. The exact cause of death could not be determined, though respiratory depression from mixed drug toxicity or fatal arrhythmia were likely. He had been assaulted in custody and was on multiple prescribed medications (mirtazapine, escitalopram, diazepam, pregabalin, baclofen) but also accessed non-prescribed medications including buprenorphine, quetiapine, and paliperidone. Combination of prescribed and non-prescribed drugs could have caused life-threatening central nervous system or respiratory depression. While medical care appeared appropriate and medication review processes were in place, systemic opportunities exist: improved inter-agency information sharing on urine drug screening results between QCS, PMHS, and PHS; therapeutic urine testing; opioid substitution programs; prisoner education on substance misuse risks at reception; and enhanced behavioural therapies.
AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes. Report an inaccuracy.
Specialties
psychiatrycorrectional healthgeneral practiceforensic medicineemergency medicine
adjustment disorderanxiety and depressive disorderneuropathic painsubstance use disorderpossible respiratory depressionpossible fatal arrhythmiapossible seizure/epilepsy
Contributing factors
Misuse of non-prescribed medications
Combination of prescribed and non-prescribed drugs at therapeutic/near-toxic levels
Prior serious assault in custody with ongoing pain management issues
History of substance misuse
Possible respiratory depression from mixed drug toxicity
Possible fatal arrhythmia from drug combinations
Limited inter-agency information sharing between correctional services and health providers
Coroner's recommendations
Implement improved information sharing about drug test results between Queensland Corrective Services (QCS), Prison Health Service (PHS) and Prison Mental Health Service (PMHS)
Increase 'therapeutic' urine testing with visibility of results to inform treatment decisions
Continue implementation of Opioid Substitution Treatment Programs with state-wide rollout
Provide prisoner/patient awareness raising of the risks of opioid misuse at reception into custody
Educate all prisoners on the risks of substance misuse and polypharmacy including overdose at point of reception and PMHS intake assessment
Utilize existing regular interagency meetings to discuss outcomes of urine drug screening and implications for treatment regimens
Continue enhanced cognitive behaviour therapy and contingency management programs
Amend Substance Testing Custodial Operations Practice Directive to allow PMHS psychiatrists to recommend prisoners for urine drug screening
Implement wastewater testing as alternative to random urine testing while maintaining targeted testing capability
This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.
Content may be incomplete, reformatted, or summarised. Some material may have been redacted or restricted by court order or privacy requirements. Always refer to the original court publication for the authoritative record.
Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction — report an inaccuracy here.